James Battiste to Glioblastoma
This is a "connection" page, showing publications James Battiste has written about Glioblastoma.
Connection Strength
1.894
-
Physical Forces in Glioblastoma Migration: A Systematic Review. Int J Mol Sci. 2022 Apr 06; 23(7).
Score: 0.702
-
A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007. J Cell Mol Med. 2022 01; 26(2):570-582.
Score: 0.172
-
Physical confinement during cancer cell migration triggers therapeutic resistance and cancer stem cell-like behavior. Cancer Lett. 2021 05 28; 506:142-151.
Score: 0.163
-
Application of microfluidic devices for glioblastoma study: current status and future directions. Biomed Microdevices. 2020 09 01; 22(3):60.
Score: 0.157
-
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma. Cancer. 2020 06 15; 126(12):2821-2828.
Score: 0.152
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
Score: 0.150
-
Glioblastoma Multiforme heterogeneity profiling with solid-state micropores. Biomed Microdevices. 2019 08 14; 21(4):79.
Score: 0.146
-
An Examination of the Role of Supramaximal Resection of Temporal Lobe Glioblastoma Multiforme. World Neurosurg. 2018 Jun; 114:e747-e755.
Score: 0.133
-
A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma. CNS Oncol. 2017 01; 6(1):29-43.
Score: 0.119